Komori
Zacros (7917) · InitiativeAdvancedLatest Earnings presentation materials (2026-08-06): "Cited as achieved"

Priority Research Areas in Life Sciences and Information Electronics

First written in FY2016. 8 of 16 entries say "Advanced", first in FY2023-Q2. Latest entry: 2026-08-06.

16entries
11years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018 – FY2019AdvancedFY2023 – FY20242016: 120162017: 120172018: 120182019: 120192020: 020202021: 020212022: 220222023: 220232024: 120242025: 220252026: 52026
Same theme, other companies
Priority Business Areas: Life Sciences, Electronic Information, and Environmental EnergyA theme 8 companies write about · 0 as a headwind · 8 as a tailwind

The whole theme swung hardest in 2017: 1 of 7 companies on the "Worse" side.

0 other companies' latest entry also says "Cited as achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「In semiconductors, we are focusing on developing high-performance films for advanced packaging for HPC (high-performance computing) and AI, based on our proprietary super-clean technology and precision thin-film coating technology. In energy-related fields, we are improving the performance of components for lithium-ion batteries (LIBs), a market that continues to expand, while accelerating the advance development of materials for next-generation batteries, including all-solid-state batteries.」

    The priority research areas were made more specific, covering advanced packaging for HPC and AI, high-performance LIB components, and materials for next-generation batteries such as all-solid-state batteries.
  2. FY2026-H1AdvancedAnnual report

    「In Electronics Materials and Other, revenue from interlayer insulating films increased due to the recovery of the semiconductor market and growth in the AI field, resulting in higher revenue for the business as a whole.」

    In the priority areas, including semiconductors and AI, revenue from interlayer insulating films increased against the backdrop of the recovering semiconductor market and growth in the AI field. Revenue in Electronics Materials and Other increased 19.6% year on year.
  3. FY2025RestatedAnnual report

    「For protective films for polarising plates, the materials and surface treatments used in polarising plates, as well as their applications, are becoming increasingly diverse. In response, we are expanding our lineup of low-contamination products with reduced peel electrification voltage, while also expanding our lineup of protective films for various processes other than polarising plates using these technologies.」

    The policy of expanding applications and the product lineup was reconfirmed for the priority research areas, including next-generation displays, semiconductors and energy-related materials.
  4. FY2024AdvancedAnnual report

    「The R&D project for the social implementation of cell-based beef was selected for NEDO's Bio-Manufacturing Revolution Promotion Project, with our company as the lead company. We are working with the principal companies and relevant academic institutions not only on technology development but also on establishing rules for social implementation.」

    The R&D policy across the 4 fields progressed to NEDO selection, the establishment of rules for social implementation, and specific activities related to cell culture and biotechnology.
  5. FY2023AdvancedAnnual report

    「As the direction of R&D over the medium to long term, we are targeting devices and systems related to pharmaceuticals and advanced medicine in wellness, environmentally considerate packaging, containers and their materials in environmental solutions, key materials for next-generation displays, semiconductors and energy-related applications in information and electronics, and products and systems for smart construction sites in building and civil engineering materials.」

    While maintaining the priority research areas across the 4 fields, the Group advanced targets such as semiconductors and smart construction sites into specific development activities.
  6. FY2023-Q3RestatedAnnual report

    「The Group's total R&D expenditure for the 3rd quarter of the cumulative consolidated period was ¥2,828 million. There were no material changes in the status of the Group's R&D activities during the 3rd quarter of the cumulative consolidated period.」

    R&D expenses of ¥2,828 million were recorded, and it was reconfirmed that there were no material changes in the status of R&D activities.
  7. FY2023-Q2AdvancedAnnual report

    「The Electronics Materials and Other segment recorded higher revenue, led by interlayer insulating materials for semiconductor packages, for which global demand is rising in information-recording applications.」

    Higher revenue was reported for semiconductor-related materials in the priority research areas, led by interlayer insulating materials for semiconductor packages.
  8. FY2022ReframedAnnual report

    「As the direction of R&D over the medium to long term, we are targeting devices and systems related to pharmaceuticals and advanced medicine in wellness, environmentally considerate packaging, containers and their materials in environmental solutions, key materials for next-generation displays, semiconductors and energy-related applications in information and electronics, and products and systems for smart construction sites in building and civil engineering materials.」

    The priority R&D areas were reorganised from the previous focus on life sciences and information and electronics into devices, environmental materials, semiconductors and energy, and smart construction sites corresponding to the 4 business areas.
  9. FY2019RestatedAnnual report

    「As the direction of R&D over the medium to long term, we are targeting pharmaceutical and advanced medicine-related and environmental applications in life sciences, and next-generation displays, energy-related materials and information devices in information and electronics.」

    The medium- to long-term R&D areas for both businesses were reconfirmed.
  10. FY2018RestatedAnnual report

    「As the direction of R&D over the medium to long term, we are targeting pharmaceutical and advanced medicine-related and environmental applications in life sciences, and next-generation displays, energy-related materials and information devices in information and electronics.」

    The priority research areas in life sciences and information and electronics were reconfirmed.
  11. FY2017ReframedAnnual report

    「As the medium- to long-term direction of R&D, we are targeting pharmaceuticals/advanced medical applications and related areas and environmental applications in life sciences, and next-generation displays, energy-related materials, and information terminals in information electronics.」

    The priority areas for R&D were updated to cover advanced medicine-related applications in life sciences and next-generation displays in information and electronics.
  12. FY2016First statedAnnual report

    「As the medium- to long-term direction of R&D, we are pursuing R&D in 3 fields in life sciences—pharmaceuticals/medical applications and related areas, environment-related applications, and biotechnology (biochemistry)—and 3 fields in information electronics—green IT, energy-related materials, and information terminals.」

    Outlined 3 medium- to long-term R&D areas for each of the 2 core businesses.
Moved together

"Strengthening Growth Drivers" moved the same way as this thread, in the same document, in 7 of its 16 moves.

765444★123456
  1. ★This thread
  2. 1Strengthening Growth Drivers7×
  3. 2Expansion of Overseas Production and Sales6×
  4. 3Improving Operating Profit, Profit Margin and ROA5×
  5. 4Building BioPhaS’s production expansion capacity4×
  6. 5Share Buybacks4×
  7. 6Stable, Ongoing Dividends and Improving ROE4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Zacros's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Earnings presentation materials of 2026-08-06: "Cited as achieved".
Priority Research Areas in Life Sciences and Information Electronics | ZACROS Corporation (7917) | Komori